PSCH vs. ARKG ETF Comparison

Comparison of PowerShares S&P SmallCap Health Care Portfolio (PSCH) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
PSCH

PowerShares S&P SmallCap Health Care Portfolio

PSCH Description

The PowerShares S&P SmallCap Health Care Portfolio (Fund) is based on the S&P SmallCap 600® Capped Health Care Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to measure the overall performance of common stocks in the health care sector. Included are healthcare companies principally engaged in the business of providing healthcare-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. The Index is a subset of the S&P SmallCap 600® Index, which is a float-adjusted, market-capitalization-weighted index reflecting the US small-cap market. The Fund and the Index are rebalanced and reconstituted quarterly.

Grade (RS Rating)

Last Trade

$40.05

Average Daily Volume

18,894

Number of Holdings *

64

* may have additional holdings in another (foreign) market
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$23.54

Average Daily Volume

2,354,214

Number of Holdings *

38

* may have additional holdings in another (foreign) market
Performance
Period PSCH ARKG
30 Days -6.27% -16.95%
60 Days -6.52% -25.12%
90 Days -3.87% -18.54%
12 Months -11.03% -22.79%
1 Overlapping Holdings
Symbol Grade Weight in PSCH Weight in ARKG Overlap
SDGR F 1.24% 4.55% 1.24%
PSCH Overweight 63 Positions Relative to ARKG
Symbol Grade Weight
ENSG C 5.91%
GKOS A 4.19%
OGN A 4.01%
MMSI D 3.68%
ALKS F 3.55%
ITGR A 3.5%
PBH C 3.0%
FTRE B 2.99%
RDNT A 2.76%
SEM B 2.57%
PINC F 2.2%
VCEL B 2.06%
CNMD F 2.05%
STAA B 2.0%
AMN F 1.91%
CRVL C 1.91%
CORT F 1.86%
PDCO F 1.85%
TNDM A 1.84%
NARI F 1.79%
ICUI F 1.74%
OMI B 1.69%
PRVA F 1.67%
CERT F 1.65%
NEO F 1.55%
CPRX A 1.52%
MYGN D 1.5%
ASTH D 1.46%
SUPN D 1.45%
UFPT A 1.42%
ADUS A 1.37%
AMPH F 1.35%
DVAX D 1.34%
USPH D 1.34%
LGND B 1.16%
LMAT C 1.13%
PCRX F 1.09%
OMCL F 1.08%
XNCR F 1.08%
NHC C 1.05%
COLL B 1.02%
IRWD F 0.95%
ANIP A 0.89%
HRMY D 0.86%
AVNS F 0.78%
RCUS F 0.78%
AHCO D 0.72%
INVA C 0.72%
MD D 0.67%
RGNX F 0.65%
SLP A 0.65%
VIR F 0.65%
VREX D 0.63%
EMBC F 0.54%
CTKB F 0.53%
CCRN F 0.52%
HSTM D 0.52%
BLFS D 0.49%
MLAB F 0.47%
FLGT F 0.37%
OSUR F 0.35%
AGTI A 0.31%
PAHC A 0.24%
PSCH Underweight 37 Positions Relative to ARKG
Symbol Grade Weight
CRSP F -7.23%
TWST D -6.08%
EXAS B -5.67%
RXRX F -5.36%
NTLA F -3.97%
TXG F -3.92%
IONS D -3.92%
BEAM F -3.87%
DNA F -3.67%
ARCT F -3.65%
CDNA F -3.54%
TDOC F -3.22%
ACCD D -3.21%
NRIX A -2.99%
MRNA A -2.76%
VCYT F -2.69%
PACB F -2.63%
VEEV D -2.61%
VRTX C -2.38%
ADPT F -1.83%
MASS F -1.72%
VERV F -1.61%
QSI F -1.53%
INCY F -1.49%
ABSI B -1.32%
CMPS F -1.31%
PATH F -1.19%
PRME F -1.17%
REGN C -1.1%
AMGN D -0.92%
CERS F -0.92%
RPTX F -0.7%
BFLY F -0.7%
PSNL F -0.57%
NTRA A -0.53%
GH F -0.44%
NVDA A -0.22%
Compare ETFs